feature image

Institutional Biosafety Committee

The Institutional Biosafety Committee is responsible for monitoring and ensuring compliance as well as review and approval of all research projects that involve recombinant or synthetic nucleic acid molecules, including human gene transfer (clinical trials) in accordance with the NIH Guidelines.

News

   Winter break happy snowperson

To a New Year!

Changes coming soon to the IBC!

Looking for the IBC Application?  Click here!

Research Guidance Tool>>